BG
RCKT icon

BlackRock Group’s Rocket Pharmaceuticals RCKT Stock Holding History

BlackRock Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$894K Sell
36,652
-48,200
-57% -$1.38M ﹤0.01% 2180
2016
Q3 		$3.22M Sell
84,852
-1,300
-2% -$40.9K ﹤0.01% 1326
2016
Q2 		$2.56M Hold
86,152
– – ﹤0.01% 1412
2016
Q1 		$2.55M Hold
86,152
– – ﹤0.01% 1388
2015
Q4 		$3.9M Hold
86,152
– – ﹤0.01% 1179
2015
Q3 		$3.24M Buy
+86,152
New +$3.96M ﹤0.01% 1254

Other funds holding RCKT

RCP
Rho Capital Partners New York $20.4M AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return